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The Basel Institute for
Immunology
What is it famous for? Its unique,
non-hierarchical structure, which
resulted from the vision of founding
director Niels Jerne. He made the
revolutionary decisions that the new
institute should be devoted entirely to
immunology, and that each researcher
should be free to choose with whom
and on what they work. The Basel
Institute for Immunology, or BII, has
no positions other than ‘member’
among the 50 scientific staff.
How is it funded? The BII was set up
25 years ago by the pharmaceutical
company Roche, which still fully
funds it to the tune of about $25
million annually. This frees members
from the tyranny of grant applications
— they receive lab space, a technician
and an annual supply budget of about
$25 000.
What does Roche get out of it? Good,
if expensive, public relations. Roche
has an option on patenting work
emerging from the BII, but rarely
takes it up; it does not determine the
direction of research.
Has it had any big successes? Niels
Jerne’s Nobel prize, awarded in 1984
for his influential ideas on specificity
and control in the immune system,
was shared with Georges Köhler,
another BII member, and César
Milstein, who jointly discovered the
principle behind producing mono-
clonal antibodies. Perhaps the most
famous son is Susumu Tonegawa,
who received the Nobel prize in
1987 for his work at the BII on the
generation of antibody diversity.
What is it like to work there? Most
members find the BII (if not Basel
itself) a stimulating, creative
environment, though some visitors
find the atmosphere of ‘joyful
disrespect’ that Jerne fostered overly
aggressive. There is a deliberate
policy of rapid turnover, which
prevents complacency; 80 % of
members are on short-term contracts,
lasting, on average, for four years. Not
surprisingly, as labs are small,
collaboration is the name of the game;
about half of all projects are
collaborations with other institutes.
Is it still non-hierarchical? In
principle, yes, though some purists
complain that the few permanent
members hold increasing sway over
the research direction of other
members, so that the principle of
individual freedom is threatened.
The biggest challenge for current
director Fritz Melchers (who
succeeded Jerne in 1980) is to ensure
that members are allowed to do their
own thing, despite the pressures of
established interests within, and
competition from outside, the BII.
What do they do for fun? Not easy in
Switzerland, but the BII Theatre for
the Arts has built a reputation for
lavish productions; its 10th
anniversary Ballet was well-reviewed
in Nature. This was topped by the
opera La Notta della battaglia, starring
Polly Matzinger as the Princess of the
B cells, slaying a virus with the help
of the ‘relatively uneducated’ T-cell
Prince (Billy Leisserson). Fritz
Melchers had a cameo role as the
Prince of Complement.
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If you have a problem, no matter how
large or small, Current Biology’s
‘agony aunt’ Amber can help.
Dear Amber,
I have a phobia about scientific meet-
ings. I am invited to speak at many
meetings, but can never persuade
myself to go. Something about the
idea of spending three or four days
trying to be civil to complete strangers
terrifies me. Can you help?
Terrified, Cambridge, UK.
Dear Terrified,
Where did you get the idea that
speakers generally spend three or four
days at a meeting, let alone spend
them being civil to strangers? Many
speakers fly in only hours before their
talk, then leave almost immediately
afterwards, and talk only to their
friends. But you may feel there’s little
point in going at all under these
circumstances, and I wouldn’t say
you’re necessarily wrong.
Amber
Dear Amber,
We are hard-working life scientists,
but our research work has never been
published in Nature or Science. How
can we get our papers accepted by
the top-notch journals?
Impatient, Taipei, Taiwan.
Dear Impatient,
If your work is high-quality and yet is
routinely rejected by the journals you
mention, there are two obvious
explanations: you may have failed to
communicate the importance of your
work, or you may simply be unlucky.
Sadly, it is not enough to have sound,
interesting results, you also need the
referees to express great enthusiasm.
Perhaps you should include some
Prozac with the referees’ copies.
Amber
Address: amber@cursci.co.uk
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Scene from the BII opera; the Princess of the
B cells in full flight.
